TolerogenixX Has Received EMA Orphan Drug Designation for MIC-Lx, Strengthening its Regulatory Pathway in Kidney Transplantation
Supporting the development of its proprietary MIC-Lx Modified Immune Cells technology as a novel approach to reduce lifelong systemic immunosuppression and improve long-term outcomes for transplant…
Read the full articleYou might also wanna read
Mini-Labor zeigt, wie Immunzellen Krebszellen angreifen
Immuntherapien sind eine vielversprechende Methode im Kampf gegen Krebs. Forschende der Technischen Universität München (TUM) haben nun das
A New Class of Therapeutics Could End Immunosuppressants
Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
The country’s new regulatory pathway promises to accelerate access to advanced therapies for Chinese patients, but may change the licensing
biopharmadive.com·1mo agoRegeneron (REGN) Receives FDA Orphan Drug Designation for Dupilumab
Related Stocks: REGN
Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant Recipients With Chronic Active Antibody-Mediated Rejection
Conditions : Antibody Mediated Rejection After Kidney Transplantation Interventions : Drug: BiTE (BCMA x CD3 Bispecific Antibody) Sponsors :
Nova tecnologia pode aprimorar a avaliacao de figado de doadores antes do transplante
Pesquisadores da Mayo Clinic, em colaboracao com o Terasaki Institute for Biomedical Innovation, desenvolveram um sistema de monitoramento e
Comments
Sign in to join the conversation.
No comments yet. Be the first.